The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer death worldwide. HCC can be cured by radical therapies if early diagnosis is done while the tumor has remained of small size. Unfortunately, diagnosis is commonly late when the tumor has grown and spread. Thus, palliative approaches are usually applied such as transarterial intrahepatic chemoembolization and sorafenib, an anti-angiogenic agent and MAP kinase inhibitor. This latter is the only targeted therapy that has shown significant, although moderate, efficiency in some individuals with advanced HCC. This highlights the need to develop other targeted therapies, and to this goal, to identify more and more pathways as potential targets. The Wnt pathway is a key component of a physiological process involved in embryonic development and tissue homeostasis. Activation of this pathway occurs when a Wnt ligand binds to a Frizzled (FZD) receptor at the cell membrane. Two different Wnt signaling cascades have been identified, called non-canonical and canonical pathways, the latter involving the β-catenin protein. Deregulation of the Wnt pathway is an early event in hepatocarcinogenesis and has been associated with an aggressive HCC phenotype, since it is implicated both in cell survival, proliferation, migration and invasion. Thus, component proteins identified in this pathway are potential candidates of pharmacological intervention. This review focuses on the characteristics and functions of the molecular targets of the Wnt signaling cascade and how they may be manipulated to achieve anti-tumor effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Llovet, J. M., Di Bisceglie, A. M., Bruix, J., Kramer, B. S., Lencioni, R., Zhu, A. X., Sherman, M., Schwartz, M., Lotze, M., Talwalkar, J., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn134 · Cited by 1,653
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Ozawa, M., Baribault, H., & Kemler, R. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03563.x · Cited by 1,396
Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,383
Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context
Mikels, A. J., & Nusse, R. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040115 · Cited by 1,252
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238 · cited 1×
“The Wnt/b-catenin activated HCC subclass without CTNNB1 mutation is characterized by dysregulation of classical Wnt targets, high chromosomal instability, aggressive phenotype, and is preferentially associated with chronic HBV infection [54,63,64].”
BackgroundYamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Suzuki, H., Watkins, D. N., Jair, K.-W., Schuebel, K. E., Markowitz, S. D., Dong Chen, W., Pretlow, T. P., Yang, B., Akiyama, Y., van Engeland, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1330 · Cited by 1,069
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Vascular Development in the Retina and Inner Ear
Xu, Q., Wang, Y., Dabdoub, A., Smallwood, P. M., Williams, J., Woods, C., Kelley, M. W., Jiang, L., Tasman, W., Zhang, K., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00216-8 · Cited by 875
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
The receptor tyrosine kinase Ror2 is involved in non‐canonical Wnt5a/JNK signalling pathway
Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I., Suzuki, K., Yamada, G., Schwabe, G. C., et al. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00662.x · Cited by 780
SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Semënov, M., Tamai, K., & He, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504308200 · Cited by 771
Hart, M., Concordet, J.-P., Lassot, I., Albert, I., del los Santos, R., Durand, H., Perret, C., Rubinfeld, B., Margottin, F., Benarous, R., et al. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80091-8 · Cited by 671
β-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628 · cited 1×
“Ser37 and Ser33 phosphorylations provide a binding site for the E3 ubiquitin ligase b-TRCP (b-transducin repeat containing protein), leading to b-catenin ubiquitination in a b-TRCP/ Skp1/cullin F-box complex (SCF) dependent manner followed by proteasomal degradation [30,31].”
BackgroundInterplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling
Heuberger, J., & Birchmeier, W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002915 · Cited by 619
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614 · cited 1×
“therapeutic agents as well [106].”
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Hirano, S., Kimoto, N., Shimoyama, Y., Hirohashi, S., & Takeichi, M. (1992) · Cell · doi:10.1016/0092-8674(92)90103-j · Cited by 554
Daniels, D. L., & Weis, W. I. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb912 · Cited by 551
Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R. T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.131-139.2003 · Cited by 541
Huelsken, J., & Behrens, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00089 · Cited by 540
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C., Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C., Smith, D. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205591 · Cited by 486
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485
Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling
Capurro, M. I., Xiang, Y.-Y., Lobe, C., & Filmus, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4244 · Cited by 469
Mammary stem cells, self-renewal pathways, and carcinogenesis
Liu, S., Dontu, G., & Wicha, M. S. (2005) · Breast Cancer Research · doi:10.1186/bcr1021 · Cited by 446
Diversity of LEF/TCF action in development and disease
Arce, L., Yokoyama, N. N., & Waterman, M. L. (2006) · Oncogene · doi:10.1038/sj.onc.1210056 · Cited by 438
Glypican-3 as a Serum Marker for Hepatocellular Carcinoma
Capurro, M., & Filmus, J. (2005) · Cancer Research · doi:10.1158/0008-5472.372.65.1 · Cited by 432
Secreted Frizzled‐related proteins: searching for relationships and patterns
Jones, S. E., & Jomary, C. (2002) · BioEssays · doi:10.1002/bies.10136 · Cited by 427
Üren, A., Reichsman, F., Anest, V., Taylor, W. G., Muraiso, K., Bottaro, D. P., Cumberledge, S., & Rubin, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4374 · Cited by 408
Crystal Structure of a β-Catenin/Tcf Complex
Graham, T. A., Weaver, C., Mao, F., Kimelman, D., & Xu, W. (2000) · Cell · doi:10.1016/s0092-8674(00)00192-6 · Cited by 405
β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation
Liu, C., Kato, Y., Zhang, Z., Do, V. M., Yankner, B. A., & He, X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6273 · Cited by 398
Proffitt, K. D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M. A., Hannoush, R. N., & Virshup, D. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2258 · Cited by 382
A new nomenclature for int-1 and related genes: The Wnt gene family
Nusse, R., Brown, A., Papkoff, J., Scambler, P., Shackleford, G., McMahon, A., Moon, R., & Varmus, H. (1991) · Cell · doi:10.1016/0092-8674(91)90633-a · Cited by 368
Vinson, C. R., Conover, S., & Adler, P. N. (1989) · Nature · doi:10.1038/338263a0 · Cited by 367
All Tcf HMG box transcription factors interact with Groucho-related co-repressors
Brantjes, H. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.7.1410 · Cited by 361
Effect of the wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster
Sharma, R. P., & Chopra, V. L. (1976) · Developmental Biology · doi:10.1016/0012-1606(76)90108-1 · Cited by 355
Bafico, A., Gazit, A., Pramila, T., Finch, P. W., Yaniv, A., & Aaronson, S. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16180 · Cited by 353
Wong, C. M., Fan, S. T., & Ng, I. O. L. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1<136::aid-cncr1301>3.0.co;2-r · Cited by 348
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
McAuliffe, S. M., Morgan, S. L., Wyant, G. A., Tran, L. T., Muto, K. W., Chen, Y. S., Chin, K. T., Partridge, J. C., Poole, B. B., Cheng, K.-H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206400109 · Cited by 328
Waaler, J., Machon, O., Tumova, L., Dinh, H., Korinek, V., Wilson, S. R., Paulsen, J. E., Pedersen, N. M., Eide, T. J., Machonova, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3336 · Cited by 328
Wise, a context-dependent activator and inhibitor of Wnt signalling
Itasaki, N., Jones, C. M., Mercurio, S., Rowe, A., Domingos, P. M., Smith, J. C., & Krumlauf, R. (2003) · Development · doi:10.1242/dev.00674 · Cited by 321 · cited 1×
“They bind to Lrp5/6 and thus disrupt the Wnt-induced FZD-Lrp5/6 interaction [48,49].”
BackgroundMedical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314 · cited 1×
“However, there are ongoing or ended clinical trials with agents that target FGF, VEGF, PDGF, EGF, IGF, mTOR, and TGFb signaling pathways but none has been shown yet to have a significant impact on patient survival [5].”
BackgroundHui, L., Zatloukal, K., Scheuch, H., Stepniak, E., & Wagner, E. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37156 · Cited by 307
Lachenmayer, A., Alsinet, C., Savic, R., Cabellos, L., Toffanin, S., Hoshida, Y., Villanueva, A., Minguez, B., Newell, P., Tsai, H.-W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2322 · Cited by 306
Senescence, apoptosis and therapy — cutting the lifelines of cancer
Schmitt, C. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1044 · Cited by 295 · cited 1×
“therapeutic treatment [89–91].”
Cancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
Nam, J.-S., Turcotte, T. J., Smith, P. F., Choi, S., & Yoon, J. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508324200 · Cited by 288
R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6
Binnerts, M. E., Kim, K.-A., Bright, J. M., Patel, S. M., Tran, K., Zhou, M., Leung, J. M., Liu, Y., Lomas, W. E., Dixon, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702305104 · Cited by 281
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma
Yamashita, T., Honda, M., Nakamoto, Y., Baba, M., Nio, K., Hara, Y., Zeng, S. S., Hayashi, T., Kondo, M., Takatori, H., et al. (2013) · Hepatology · doi:10.1002/hep.26168 · Cited by 281
Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells
He, B., You, L., Uematsu, K., Xu, Z., Lee, A. Y., Matsangou, M., McCormick, F., & Jablons, D. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80048-4 · Cited by 269
You, L., He, B., Xu, Z., Uematsu, K., Mazieres, J., Mikami, I., Reguart, N., Moody, T. W., Kitajewski, J., McCormick, F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207844 · Cited by 258
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.009 · Cited by 249
Self-citationFujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232
Lu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029290 · Cited by 230 · cited 1×
“Therapeutic small molecules, such as niclosamide and silibinin, display anti-tumor activity in vitro and in vivo by suppressing Lrp6 expression, leading to inhibition of Wnt/b-catenin signaling in human prostate and breast tumor cells, as well as by promoting induction of apoptosis [114,115].”
BackgroundEpidermal Growth Factor Receptor: A Novel Target of the Wnt/β-Catenin Pathway in Liver
Tan, X., Apte, U., Micsenyi, A., Kotsagrelos, E., Luo, J.-H., Ranganathan, S., Monga, D. K., Bell, A., Michalopoulos, G. K., & Monga, S. P. S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.013 · Cited by 219
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
Yuzugullu, H., Benhaj, K., Ozturk, N., Senturk, S., Celik, E., Toylu, A., Tasdemir, N., Yilmaz, M., Erdal, E., Akcali, K. C., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-90 · Cited by 215
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
Bengochea, A., de Souza, M. M., Lefrançois, L., Le Roux, E., Galy, O., Chemin, I., Kim, M., Wands, J. R., Trepo, C., Hainaut, P., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604422 · Cited by 215 · cited 1×
“Indeed, upregulation of activators, such as ligands (Wnt1/3/4/5a/10b) or receptors/coreceptors (FZD3/6/7, Lrp6), and downregulation of inhibitors (sFRP1/4/5, Wif1, Dkk3, Dkk4) have been reported both in HCC tumors and surrounding precancerous liver tissues, which emphasizes that their over and/or underexpression may b…”
BackgroundSelf-citationHe, B., Reguart, N., You, L., Mazieres, J., Xu, Z., Lee, A. Y., Mikami, I., McCormick, F., & Jablons, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208511 · Cited by 212
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
Kawada, N., Imanaka, K., Kawaguchi, T., Tamai, C., Ishihara, R., Matsunaga, T., Gotoh, K., Yamada, T., & Tomita, Y. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0112-0 · Cited by 204
You, L., He, B., Xu, Z., Uematsu, K., Mazieres, J., Fujii, N., Mikami, I., Reguart, N., McIntosh, J. K., Kashani-Sabet, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1227 · Cited by 194
Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
Harada, N., Oshima, H., Katoh, M., Tamai, Y., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2123 · Cited by 194
Targeting the Wnt/β-catenin signaling pathway in human cancers
Yao, H., Ashihara, E., & Maekawa, T. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.577418 · Cited by 184
A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities
Handeli, S., & Simon, J. A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2063 · Cited by 183
Kim, M., Lee, H. C., Tsedensodnom, O., Hartley, R., Lim, Y.-S., Yu, E., Merle, P., & Wands, J. R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.020 · Cited by 179
Self-citationRhee, C.-S., Sen, M., Lu, D., Wu, C., Leoni, L., Rubin, J., Corr, M., & Carson, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205920 · Cited by 179
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cadoret, A., Ovejero, C., Saadi-Kheddouci, S., Souil, E., Fabrè, M., Romagnolo, B., Kahn, A., & Perret, C. (2001) · PubMed · Cited by 169
Nejak‐Bowen, K. N., Thompson, M. D., Singh, S., Bowen, W. C., Dar, M. J., Khillan, J. S., Dai, C., & Monga, S. P. (2010) · Hepatology · doi:10.1002/hep.23538 · Cited by 168
Planar cell polarity signaling in vertebrates
Jones, C., & Chen, P. (2007) · BioEssays · doi:10.1002/bies.20526 · Cited by 166
Harada, N., Miyoshi, H., Murai, N., Oshima, H., Tamai, Y., Oshima, M., & Taketo, M. M. (2002) · PubMed · Cited by 164
Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Bao, R., Christova, T., Song, S., Angers, S., Yan, X., & Attisano, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048670 · Cited by 161
Frizzled7 as an emerging target for cancer therapy
King, T. D., Zhang, W., Suto, M. J., & Li, Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.009 · Cited by 158
Wei, W., Chua, M., Grepper, S., & So, S. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24810 · Cited by 146
Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma
Hu, J., Dong, A., Fernández-Ruiz, V., Shan, J., Kawa, M. P., Martínez‐Ansó, E., Prìeto, J., & Qian, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0541 · Cited by 138
A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals
Tanaka, S., Akiyoshi, T., Mori, M., Wands, J. R., & Sugimachi, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10164 · Cited by 138
Self-citationLü, W., Lin, C., King, T. D., Chen, H., Reynolds, R. C., & Li, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.009 · Cited by 127
siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
Zeng, G., Apte, U. M., Cieply, B. W., Singh, S., & Monga, S. P. (2007) · Neoplasia · doi:10.1593/neo.07469 · Cited by 122
Gebhardt, R., & Hovhannisyan, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22041 · Cited by 112
Wei, W., Chua, M., Grepper, S., & So, S. K. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-16 · Cited by 110
van Ooyen, A., Kwee, V., & Nusse, R. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04021.x · Cited by 108
Zhang, X., Tan, X., Zeng, G., Missé, A., Singh, S., Kim, Y., Klaunig, J. E., & Monga, S. P. (2010) · Hepatology · doi:10.1002/hep.23747 · Cited by 107
Suzuki, T., Yano, H., Nakashima, Y., Nakashima, O., & Kojiro, M. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02774.x · Cited by 101
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
Wei, W., Chua, M., Grepper, S., & So, S. K. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-76 · Cited by 101
Wang, K., Zhang, Y., Li, X., Chen, L., Wang, H., Wu, J., Zheng, J., & Wu, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802376200 · Cited by 99
Wnt Antagonist SFRP1 Functions as a Secreted Mediator of Senescence
Elzi, D. J., Song, M., Hakala, K. W., Weintraub, S. T., & Shiio, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06023-11 · Cited by 97
Noncanonical Wnt11 Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration
Toyama, T., Lee, H. C., Koga, H., Wands, J. R., & Kim, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0238 · Cited by 97
Self-citationPharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma
Nambotin, S. B., Lefrançois, L., Sainsily, X., Berthillon, P., Kim, M., Wands, J. R., Chevallier, M., Jalinot, P., Scoazec, J., TREPO, C. G., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.033 · Cited by 95
Self-citationPode‐Shakked, N., Harari‐Steinberg, O., Haberman-Ziv, Y., Rom‐Gross, E., Bahar, S., Omer, D. S., Metsuyanim, S., Buzhor, E., Jacob–Hirsch, J., Goldstein, R. S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.549 · Cited by 94
Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
Stauffer, J. K., Scarzello, A. J., Andersen, J. B., Kluyver, R. L. D., Back, T. C., Weiss, J. M., Thorgeirsson, S. S., & Wiltrout, R. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2705 · Cited by 89
Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy
Lee, K., Hu, Y., Ding, L., Chen, Y., Takahashi, Y., Mott, R., & Ma, J. (2012) · Diabetes · doi:10.2337/db11-0300 · Cited by 86
Takahashi‐Yanaga, F., & Sasaguri, T. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r28fm · Cited by 84
Upregulation of the Wnt Co-Receptor LRP6 Promotes Hepatocarcinogenesis and Enhances Cell Invasion
Tung, E. K. K., Wong, B. Y.-C., Yau, T.-O., & Ng, I. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036565 · Cited by 83
Patthy, L. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01504-2 · Cited by 83
Hanaki, H., Yamamoto, H., Sakane, H., Matsumoto, S., Ohdan, H., Sato, A., & Kikuchi, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0682 · Cited by 82
Mutations of β‐catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis
Park, J. Y., Park, W. S., Nam, S. W., Kim, S. Y., Lee, S. H., Yoo, N. J., Lee, J. Y., & Park, C. K. (2005) · Liver International · doi:10.1111/j.1478-3231.2004.0995.x · Cited by 81
Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma
Ding, Z., Qian, Y., Zhu, L., & Xiong, Q. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2595 · Cited by 74
Longato, L., de la Monte, S. M., Kuzushita, N., Horimoto, M., Rogers, A. B., Slagle, B. L., & Wands, J. R. (2009) · Hepatology · doi:10.1002/hep.22856 · Cited by 73
Self-citationWnt2 as a new therapeutic target in malignant pleural mesothelioma
Mazières, J., You, L., He, B., Xu, Z., Twogood, S., Lee, A. Y., Reguart, N., Batra, S., Mikami, I., & Jablons, D. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21160 · Cited by 69
Rignall, B., Braeuning, A., Buchmann, A., & Schwarz, M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq226 · Cited by 68
Qin, X., Zhang, H., Zhou, X., Wang, C., Zhang, H., Zhang, X., & Ye, L. (2007) · Translational research · doi:10.1016/j.trsl.2007.06.005 · Cited by 59
Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma
Fatima, S., Lee, N. P. Y., Tsang, F. H., Kolligs, F. T., Ng, I. O., Poon, R. T. P., Fan, S. T., & Luk, J. M. (2012) · Oncogene · doi:10.1038/onc.2011.580 · Cited by 58
Evolution of Genomic Instability in Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice Δ
Aleksic, K., Lackner, C., Geigl, J. B., Schwarz, M., Auer, M., Ulz, P., Fischer, M., Trajanoski, Z., Otte, M., & Speicher, M. R. (2010) · Hepatology · doi:10.1002/hep.24133 · Cited by 58
Hepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions
Wickline, E. D., Awuah, P. K., Behari, J., Ross, M., Stolz, D. B., & Monga, S. P. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.014 · Cited by 58
Wickline, E. D., Du, Y., Stolz, D. B., Kahn, M., & Monga, S. P. (2013) · Neoplasia · doi:10.1593/neo.122098 · Cited by 57
Yoshikawa, H., Matsubara, K., Zhou, X., Okamura, S., Kubo, T., Murase, Y., Shikauchi, Y., Esteller, M., Herman, J. G., Wang, X. W., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0889 · Cited by 54
Efficacy of Wnt-1 monoclonal antibody in sarcoma cells
Mikami, I., You, L., He, B., Xu, Z., Batra, S., Lee, A. Y., Mazières, J., Reguart, N., Uematsu, K., Koizumi, K., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-53 · Cited by 52
Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin
Thompson, M. D., Dar, M. J., & Monga, S. P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.020 · Cited by 52
Zhang, Z., Rankin, S. A., & Zorn, A. M. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.02.024 · Cited by 50
Armstrong, A. R., Ryu, Y. K., Chieco, D., & Kuruvilla, R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4243-10.2011 · Cited by 48
Hepatocellular carcinoma development induced by conditional β‐catenin activation in Lkb1+/− mice
Miyoshi, H., Deguchi, A., Nakau, M., Kojima, Y., Mori, A., Oshima, M., Aoki, M., & Taketo, M. M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01284.x · Cited by 39
Lee, H., Uen, Y., Tian, Y., Sun, C., Sheu, M., Kuo, H., Koay, L., Lin, C., Tzeng, C., Cheng, C.-J., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0039 · Cited by 36
Gwak, J., Lee, J.-H., Chung, Y.-H., Song, G., & Oh, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046697 · Cited by 35
Amaddeo, G., Guichard, C., Imbeaud, S., & Zucman‐Rossi, J. (2012) · OncoImmunology · doi:10.4161/onci.21480 · Cited by 32
Epigenetic silencing of WIF-1 in hepatocellular carcinomas
Deng, Y., Yu, B., Cheng, Q., Jin, J., You, H., Ke, R., Tang, N., Shen, Q., Shu, H., Yao, G., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0763-5 · Cited by 30
Meng (2010) · Oncology Reports · doi:10.3892/or_00000960 · Cited by 27
Chen, F., Li, Y., Wang, L., & Hu, L. (2010) · Medical Oncology · doi:10.1007/s12032-010-9634-9 · Cited by 20
Lu, F. L., Yu, C.-C., Chiu, H.-H., Liu, H. E., Chen, S.-Y., Lin, S., Goh, T.-Y., Hsu, H.-C., Chien, C.-H., Wu, H., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9908-5 · Cited by 16
Guo, K., Li, Y., Kang, X., Sun, L., Cui, J., Gao, D., & Liu, Y. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9230-y · Cited by 15
Cited by
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Wnt–β-catenin signalling in liver development, health and disease
Perugorria, M. J., Olaizola, P., Labiano, I., Esparza-Baquer, A., Marzioni, M., Marin, J. J. G., Bujanda, L., & Banales, J. M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0075-9 · Cited by 605
Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology
Russell, J. O., & Monga, S. P. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044010 · Cited by 471
“calmodulin-dependent kinase II (CaMKII) and calcineurin (CaN), which regulate cell migration and proliferation (24, 25).”
BackgroundGlypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Zhou, F., Shang, W., Yu, X., & Tian, J. (2018) · Medicinal Research Reviews · doi:10.1002/med.21455 · Cited by 397
WNT/β-catenin signaling in the development of liver cancers
He, S., & Tang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110851 · Cited by 351
Metadata
- Authors
- Pez, F., Lopez, A., Kim, M., Wands, J. R., Caron de Fromentel, C., & Merle, P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 59
- Issue
- 5
- Pages
- 1107-1117
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2045459429
- Cited by
- 294
- References
- 131
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.